Skip to main content
OpenTrials
Completed

NCT Number: NCT02500368

A Dispensing Clinical Trial of a Study Test Silicone Hydrogel Lens Against Control Lens Over 1 Week

This is a 1-week dispensing, double-masked, randomized, bilateral study comparing the test lens against the control lens.

Completed

Looking for future studies?

Notify Me

Key information

Age range

17 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center for Contact Lens Research, University of Waterloo

Waterloo, Ontario, N2L 3G1, Canada

About this study

The order of lens wear (test lens first, control lens second or control lens first, test lens second) will be selected according to a randomization table.

Both test and control lenses will be used in a daily wear modality for 1 week. It is anticipated that this study will involve following visits: Baseline (screening and dispense of 1st study pair of lenses, visit combined), 1-week visit (follow-up of the 1st study pair of lenses and dispense the 2nd study pair of lenses) and 2-week visit (1 week follow-up of the 2nd study pair of lenses).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-A person is eligible for inclusion in the study if he/she:

  • Is at least 17 years of age and has full legal capacity to volunteer
  • Has read and understood the information consent letter
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Is correctable to a visual acuity of 20/30 or better (in each eye) with their habitual correction and the assigned study lenses
  • Is an adapted soft contact lens wearer (For the purpose of this study: Current lens wear at least 3 days per week, 8 hours each day.)

Exclusion criteria

-A person will be excluded from the study if he/she:

  • Is participating in any concurrent clinical or research study
  • Has any known active* ocular disease and/or infection
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable**
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study
  • Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit).
  • Is aphakic
  • Has undergone corneal refractive surgery.

For the purposes of this study, active* ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active. Participants will be excluded with significant slit lamp findings (e.g. infiltrates or other slit lamp findings Grade 3 or above: corneal edema, tarsal abnormalities, and conjunctival injection) or active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology)

For the purposes of this study, participants will be excluded**, if currently taking medication, such as oral antihistamines, antihistamine eye drops, oral and ophthalmic beta-adrenergic blockers (e.g. Propanolol, Timolol), anticholinergics, oral steroids and any prescribed or over-the-counter eye medication, except artificial tears or eye lubricants

Treatment and study plan

silicone hydrogel lens (test)

Device

contact lens

enfilcon A lens (control)

Device

contact lens

Primary outcomes

  1. Comfort

    Time frame: Baseline and 1 week

    Subjective ratings scale (0-100) assessed: 0=Cannot be worn, causes pain, 20=Frequently irritating, 40=Occasionally irritating, 60=Occasionally noticable but not irritating, 80=Rarely noticeable, 100=Cannot be felt ever. Time points for comfort: lens dispense at baseline, lens insertion at 1 week, and overall at 1 week.

  2. Dryness

    Time frame: Baseline and 1 week

    Subjective ratings scale (0-100): 0=Cannot be worn, extremely dry, 20=Frequently Irritating, 40=Occasionally irritating, 60=Occasionally noticeable but not irritating, 80=Rarely noticeable, 100=No dryness experienced at any time. Time points for dryness: lens dispense at baseline, lens insertion at 1 week, and overall at 1 week.

Secondary outcomes

  1. Lens Wettability

    Time frame: Baseline and 1 week

    Grading scale 0-4, 0.25 steps, 0=excellent; 4=severely reduced.

  2. Surface Appearance

    Time frame: Baseline

    Grade ratings category (smooth, grainy, or other)

  3. Surface Appearance

    Time frame: 1 week

    Grade ratings category (smooth, grainy, or other)

  4. High Contrast Acuity at High Room Illumination

    Time frame: Baseline and 1 week

    Logarithm of the Minimum Angle or Resolution (LogMAR) Chart

  5. Lens Deposition

    Time frame: Baseline and 1 week

    Lens Deposits Scale 0-4, 0.25 steps. 0=excellent; 4=severely reduced

  6. Lens Problems

    Time frame: Baseline and 1 week

    Lenses were evaluated for defects, scratches, fibers, blue specks, and other findings.

  7. Lens Centration

    Time frame: Baseline

    Lens centration was evaluated by the conjunctival overlap to determine whether lens was slightly or excessively decentered.

    (mm, 0.1 steps) N - Nasal, T - Temporal, S - Superior, I - Interior, N/S - Nasal/Superior, N/I - Nasal/Interior, T/S - Temporal/Superior T/I - Temporal/Interior

  8. Lens Centration

    Time frame: 1 week

    Lens centration was evaluated by the conjunctival overlap to determine whether lens was slightly or excessively decentered.

    (mm, 0.1 steps) N - Nasal, T - Temporal, S - Superior, I - Interior, N/S - Nasal/Superior, N/I - Nasal/Interior, T/S - Temporal/Superior T/I - Temporal/Interior

  9. Post-blink Movement

    Time frame: Baseline and 1 week

    Post-blink movement evaluated by estimating the distance the lens was moving immediately after a blink. Primary Gaze: (mm, 0.1 steps)

  10. Lens Tightness

    Time frame: Baseline and 1 week

    Lens tightness Scale 0%-100%, 0%=extremely loose fit, 50%=optimal push resistance and smooth return, 100%=no movement.

  11. Visual Quality

    Time frame: Baseline and 1 week

    Subjective ratings scale (0-100): 0=Extremely poor vision all of the time; cannot function, 20=Frequently annoying vision problems, 40=Occasionally annoying vision problems, 60=Occasionally noticeable but not annoying vision problems, 80=Rarely noticeable vision problems, 100=Excellent vision all of the time. Different time points were taken for vision quality: lens dispense at baseline, lens insertion at 1 week, and overall at 1 week.

  12. Ease of Lens Insertion

    Time frame: Baseline and 1 week

    Subjective ratings scale (0-100): 0=Could not place lens on eye, 20=Frequently takes multiple attempts to place on eye; often unsuccessful, 40=Frequently takes multiple attempts to place on eye, 60=Occasionally takes a few attempts to place on eye, 80=Rarely difficult to place on eye, 100=Always easy to place lens on eye

  13. Ease of Lens Removal

    Time frame: 1 week

    Subjective ratings scale (0-100): 0=Could not remove lens from eye, 20=Frequently takes multiple attempts to remove from eye; often unsuccessful, 40=Frequently takes multiple attempts to remove from eye, 60=Occasionally takes a few attempts to remove from eye, 80=Rarely difficult to remove from eye, 100=Always easy to remove lens from eye.

  14. Overall Lens Fit

    Time frame: Baseline and 1 week

    Overall Lens Fit Scale 0-4, 0.25 steps 0=Very poor (lens should not be worn at all);

    • Poor (lens could be worn with supervision only);
    • Fair (would prefer to refit, but clinically acceptable);
    • Good (fit could be slightly improved);
    • Very good (optimal)
  15. Bulbar Hyperemia

    Time frame: Baseline and 1 week

    Bulbar hyperemia assessed using scale 0-4, 0.5 steps, 0=No hyperemia, 4=Severe hyperemia.

  16. Limbal Hyperemia

    Time frame: Baseline and 1 week

    Limbal hyperemia assessed using scale 0-4, 0.5 steps, 0=No hyperemia, 4=Severe hyperemia.

  17. Corneal Dehydration Staining

    Time frame: 1 week

    Corneal Staining: Dehydration Staining: Yes/No

  18. Corneal Staining (Extent)

    Time frame: Baseline and 1 week

    Corneal staining extent, grade as % of each zone:

    C - Central, N - Nasal, T - Temporal, S - Superior, I - Interior

  19. Conjunctival Indentation

    Time frame: Baseline and 1 week.

    Conjunctival Indentation 5 locations (central, nasal, temporal, superior, inferior): Scale 0-4, 0.5 steps; 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

  20. Conjunctival Staining

    Time frame: Baseline and 1 week

    Conjunctival Staining 5 locations (central, nasal, temporal, superior, inferior): Scale 0-4; 0.5 steps, 0=None,1=Minimal diffuse punctuate, 2=Coalescent punctuate, 3=Confluent, 4=Deep confluent

Sponsors and collaborators

Lead sponsor

CooperVision, Inc.

Industry

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Jul 16, 2015
Registry last updated
Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.